HA
XYL icon

Huntleigh Advisors’s Xylem XYL Stock Holding History

Huntleigh Advisors’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,766
Closed -$211K – 330
2026
Q1 		$211K Sell
1,766
-70
-4% -$9.18K 0.04% 261
2025
Q4 		$250K Sell
1,836
-124
-6% -$17.8K 0.04% 231
2025
Q3 		$289K Sell
1,960
-345
-15% -$47.8K 0.05% 219
2025
Q2 		$298K Sell
2,305
-35
-1% -$4.24K 0.06% 208
2025
Q1 		$280K Sell
2,340
-21
-0.9% -$2.6K 0.07% 201
2024
Q4 		$274K Buy
+2,361
New +$298K 0.06% 206

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Huntleigh Advisors's XYL Position: Q2 2026 in Review

Huntleigh Advisors sold out of Xylem (XYL) in Q2 2026, closing a stake of 1,766 shares — an estimated $211K sold.

Huntleigh Advisors first reported a position in XYL in Q4 2024 and held it in 6 quarters. The position peaked at $298K in Q2 2025. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Huntleigh Advisors reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Huntleigh Advisors sold 1,766 Xylem shares in Q2 2026, an estimated $211K.
  • Huntleigh Advisors first reported a position in Xylem in Q4 2024 and held it in 6 quarters.
  • Huntleigh Advisors's Xylem position peaked at $298K in Q2 2025.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.